HuGE Literature Finder
Records
1
-
30
| The role of ABCB1 gene polymorphisms in steroid-resistant nephrotic syndrome: Evidence from a meta-analysis of steroid-receiving patients. The journal of gene medicine 2022 Jun e3436. Aziz Md Abdul, Islam Mohammad Safiq |
| Assessment of the Link of ABCB1 and NR3C1 gene polymorphisms with the prednisolone resistance in pediatric nephrotic syndrome patients of Bangladesh: A genotype and haplotype approach. Journal of advanced research 2021 Nov 33 141-151. Parvin Most Nazma, Aziz Md Abdul, Rabbi Sikder Nahidul Islam, Al-Mamun Mir Md Abdullah, Hanif Mohammed, Islam Md Saiful, Islam Mohammad Safiq |
| The influence of acute coronary syndrome on levels of clopidogrel active metabolite and platelet inhibition in patients with and without CYP2C19*2(681 G>A), *3(636 G>A) and ABCB1(C3435C> T) gene polymorphisms. Postepy w kardiologii interwencyjnej = Advances in interventional cardiology 2021 Jun 17 (2): 179-186. Wójcik Tomasz, Karolko Bo?ena, Wi?niewski Jerzy, Mysiak Andrzej, ?ciborski Krzysztof, Onisk Grzegorz, Lebioda Arleta, Jonkisz Anna, Protasiewicz Marc |
| Original and generic clopidogrel: A comparison of antiplatelet effects and active metabolite concentrations in patients without polymorphisms in the ABCB1 gene and the allele variants CYPC19*2 and *3. Advances in clinical and experimental medicine : official organ Wroclaw Medical University 2021 May . Wójcik Tomasz, Szymkiewicz Pawe?, ?ciborski Krzysztof, ?ukaszewski Marceli, Onisk Grzegorz, Mysiak Andrzej, Gamian Andrzej, Wi?niewski Jerzy, Dobosz Tadeusz, Lebioda Arleta, Jonkisz Anna, Protasiewicz Marc |
| Pharmacogenetics of the Central Nervous System-Toxicity and Relapse Affecting the CNS in Pediatric Acute Lymphoblastic Leukemia. Cancers 2021 May 13 (10): . Sági Judit C, Gézsi András, Egyed Bálint, Jakab Zsuzsanna, Benedek Noémi, Attarbaschi Andishe, Köhrer Stefan, Sipek Jakub, Winkowska Lucie, Zaliova Marketa, Anastasopoulou Stavroula, Wolthers Benjamin Ole, Ranta Susanna, Szalai Csaba, Kovács Gábor T, Semsei Ágnes F, Erdélyi Dániel |
| A Systematic Review and Meta-Analysis of Pharmacogenetic Studies in Patients with Chronic Kidney Disease. International journal of molecular sciences 2021 4 22 (9): . Tziastoudi Maria, Pissas Georgios, Raptis Georgios, Cholevas Christos, Eleftheriadis Theodoros, Dounousi Evangelia, Stefanidis Ioannis, Theoharides Theoharis |
| Meta-Analysis of ABCG2 and ABCB1 Polymorphisms With Sunitinib-Induced Toxicity and Efficacy in Renal Cell Carcinoma. Frontiers in pharmacology 2021 3 12 641075. Sun Fengjun, Chen Zhuo, Yao Pu, Weng Bangbi, Liu Zhirui, Cheng L |
| The effects of polymorphisms in CYP2C19, ATP-binding cassette transporter B1, and paraoxonase-1 on clopidogrel treatment of Uygur patients following percutaneous coronary intervention. European journal of clinical pharmacology 2021 6 77 (11): 1679-1686. Wang Tingting, Li Hongjian, Wang Fengxia, Sun Li, Yu Luh |
| Diltiazem on tacrolimus exposure and dose sparing in Chinese pediatric primary nephrotic syndrome: impact of CYP3A4, CYP3A5, ABCB1, and SLCO1B3 polymorphisms. European journal of clinical pharmacology 2020 Aug . Wang Junyan, Huang Lingfei, Gao Peng, Hu Yan, Ni Yinghua, Zhu Zhengyi, Zhang Liwen, Yang Jufei, Zhang Huifen, Fang L |
| Impact of Continuous P2Y12 Inhibition Tailoring in Acute Coronary Syndrome and Genetically Impaired Clopidogrel Absorption. Journal of cardiovascular pharmacology 2020 Feb 75 (2): 174-179. Samardzic Jure, Bozina Nada, Skoric Bosko, Ganoci Lana, Krpan Miroslav, Petricevic Mate, Pasalic Marijan, Bozina Tamara, Pavasovic Sasa, Cikes Maja, Milicic Dav |
| CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban. Pharmacogenomics and personalized medicine 2020 3 13 29-37. Sychev D A, Baturina O A, Mirzaev K B, Rytkin E, Ivashchenko D V, Andreev D A, Ryzhikova K A, Grishina E A, Bochkov P O, Shevchenko R |
| Effects of the ABCB1 C3435T single nucleotide polymorphism on major adverse cardiovascular events in acute coronary syndrome or coronary artery disease patients undergoing percutaneous coronary intervention and treated with clopidogrel: A systematic review and meta-analysis. Expert opinion on drug safety 2020 10 19 (12): 1605-1616. Biswas Mohitosh, Rahaman Shawonur, Biswas Tapash Kumar, Ibrahim Baharud |
| Relevance of Pharmacogenomics and Multidisciplinary Management in a Young-Elderly Patient With KRAS Mutant Colorectal Cancer Treated With First-Line Aflibercept-Containing Chemotherapy. Frontiers in oncology 2020 8 10 1155. Bruera Gemma, D'Andrilli Antonio, Simmaco Maurizio, Guadagni Stefano, Rendina Erino Angelo, Ricevuto Enri |
| ABCB1 and DRD3 polymorphism as a response predicting biomarker and tool for pharmacogenetically guided clozapine dosing in Asian Indian treatment resistant schizophrenia patients. Asian journal of psychiatry 2019 Dec 48 101918. M Naveen, Patil Amol N, Pattanaik Smita, Kaur Anit, Banerjee Dibyajyoti, Grover Sande |
| Population pharmacokinetic study of tacrolimus in pediatric patients with primary nephrotic syndrome: A comparison of linear and nonlinear Michaelis-Menten pharmacokinetic model. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2019 Dec 143 105199. Huang Lingfei, Liu Yixi, Jiao Zheng, Wang Junyan, Fang Luo, Mao Jianh |
| Association of CYP2C19 Polymorphism with Clopidogrel Resistance in Patients with Acute Coronary Syndrome in China. Medical science monitor : international medical journal of experimental and clinical research 2019 Sep 25 7138-7148. Su Qiang, Li Jian, Tang Zhili, Yang Siyun, Xing Guoqiang, Liu Tao, Peng Ho |
| Influence of CYP3A4/5 and ABC transporter polymorphisms on lenvatinib plasma trough concentrations in Japanese patients with thyroid cancer. Scientific reports 2019 Apr 9 (1): 5404. Ozeki Tomoko, Nagahama Mitsuji, Fujita Kazuma, Suzuki Akifumi, Sugino Kiminori, Ito Koichi, Miura Masato |
| Both CYP2C19 and PON1 Q192R Genotypes Influence Platelet Response to Clopidogrel by Thrombelastography in Patients with Acute Coronary Syndrome. Cardiovascular therapeutics 2019 2019 3470145. Peng Wenxing, Shi Xiujin, Xu Xiaoyu, Lin Ya |
| Distribution of polymorphisms in the CYP2C19 and ABCB1 genes among patients with acute coronary syndrome in Lower Silesian population. Advances in clinical and experimental medicine : official organ Wroclaw Medical University 2019 11 28 (12): 1621-1626. Wójcik Tomasz, Szymkiewicz Pawe?, Wi?niewski Jerzy, Lebioda Arleta, Jonkisz Anna, Gamian Andrzej, Kuliczkowski Wiktor, ?ciborski Krzysztof, Mysiak Andrzej, Protasiewicz Marc |
| Impact of CYP3A4/5 and ABCB1 polymorphisms on tacrolimus exposure and response in pediatric primary nephrotic syndrome. Pharmacogenomics 2019 10 20 (15): 1071-1083. Huang Lingfei, Wang Junyan, Yang Jufei, Zhang Huifen, Ni Yinghua, Zhu Zhengyi, Wang Huijuan, Gao Peng, Wu Yuanyuan, Mao Jianhua, Fang L |
| Clustering of ABCB1 and CYP2C19 Genetic Variants Predicts Risk of Major Bleeding and Thrombotic Events in Elderly Patients with Acute Coronary Syndrome Receiving Dual Antiplatelet Therapy with Aspirin and Clopidogrel. Drugs & aging 2018 Jun . Galeazzi Roberta, Olivieri Fabiola, Spazzafumo Liana, Rose Giuseppina, Montesanto Alberto, Giovagnetti Simona, Cecchini Sara, Malatesta Gelsomina, Di Pillo Raffaele, Antonicelli Rober |
| Effect of CYP3 A4, CYP3 A5 and ABCB1 gene polymorphisms on the clinical efficacy of tacrolimus in the treatment of nephrotic syndrome. BMC pharmacology & toxicology 2018 Apr 19 (1): 14. Li Min, Xu Min, Liu Wei, Gao X |
| Pharmacogenetics-based area-under-curve model can predict efficacy and adverse events from axitinib in individual patients with advanced renal cell carcinoma. Oncotarget 2018 Mar 9 (24): 17160-17170. Yamamoto Yoshiaki, Tsunedomi Ryouichi, Fujita Yusuke, Otori Toru, Ohba Mitsuyoshi, Kawai Yoshihisa, Hirata Hiroshi, Matsumoto Hiroaki, Haginaka Jun, Suzuki Shigeo, Dahiya Rajvir, Hamamoto Yoshihiko, Matsuyama Kenji, Hazama Shoichi, Nagano Hiroaki, Matsuyama Hideya |
| Opioid-related genetic polymorphisms do not influence postoperative opioid requirement: A prospective observational study. European journal of anaesthesiology 2018 Feb . Aubrun Frédéric, Zahr Noël, Langeron Olivier, Boccheciampe Nicolas, Cozic Nathalie, Belin Lisa, Hulot Jean-Sebastien, Khiami Frederic, Riou Bru |
| Pharmacogenetic landscape of Metabolic Syndrome components drug response in Tunisia and comparison with worldwide populations. PloS one 2018 13 (4): e0194842. Jmel Haifa, Romdhane Lilia, Ben Halima Yosra, Hechmi Meriem, Naouali Chokri, Dallali Hamza, Hamdi Yosr, Shan Jingxuan, Abid Abdelmajid, Jamoussi Henda, Trabelsi Sameh, Chouchane Lotfi, Luiselli Donata, Abdelhak Sonia, Kefi R |
| Pharmacogenetics and prediction of adverse events in prescription opioid use disorder patients. Basic & clinical pharmacology & toxicology 2018 12 124 (4): 439-448. Muriel Javier, Margarit César, Barrachina Jordi, Ballester Pura, Flor Andrea, Morales Domingo, Horga José F, Fernández Eduardo, Peiró Ana |
| Prevalence of pharmacogenomic variants affecting the efficacy of clopidogrel therapy in the Hispanic Community Health Study/Study of Latinos cohort. Pharmacogenomics 2018 12 20 (2): 75-83. Melin Kyle, Moon Jee-Young, Qi Qibin, Hernandez-Suarez Dagmar F, Duconge Jorge, Hua Simin, Gonzalez Sara, Zeng Donglin, Kaplan Robert |
| The role of pharmacogenetics of cytochrome P450s in phenytoin-induced DRESS syndrome. Central-European journal of immunology 2018 43 (2): 220-221. Ya?ar Üm |
| ABCB1 and CYP2D6 polymorphisms and treatment response of psychotic patients in a naturalistic setting. Human psychopharmacology 2017 Dec . Papazisis Georgios, Goulas Antonios, Sarrigiannidis Alexios, Bargiota Stavroula, Antoniadis Diomidis, Raikos Nikolaos, Basgiouraki Emmanouela, Bozikas Vasileios P, Garyfallos Georgi |
| Do CYP2C19 and ABCB1 gene polymorphisms and low CYP3A4 isoenzyme activity have an impact on stent implantation complications in acute coronary syndrome patients? Pharmacogenomics and personalized medicine 2017 10 10 243-245. Rytkin Eric, Mirzaev Karin B, Grishina Elena A, Smirnov Valeriy V, Ryzhikova Kristina A, Sozaeva Zhannet A, Giliarov Michael Iu, Andreev Denis A, Sychev Dmitriy |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: